SHANGHAI – For the first time in its 12-year history, the International Conference for Rare Diseases and Orphan Drugs (ICORD) convened its annual event in China. The event marks a milestone for the local event partner, the Chinese Organization for Rare Disorders (CORD), a patient advocacy non-governmental organization that has managed to thrive in China's harsh civil society climate.